| name | es-ghc-bg-monitoring |
| description | This skill ensures ongoing blood glucose monitoring with adjustment of insulin dosing to manage glucocorticoid-associated hyperglycemia and prevent hypoglycemia during taper or discontinuation. It is triggered when clinicians ask, "Do we need to adjust insulin doses as glucocorticoids change?" |
Implement ongoing blood glucose monitoring and insulin dose adjustment
STEP 1 — Gather Information
Collect current glucocorticoid type, dose, and schedule; recent point-of-care blood glucose (POC-BG) values (fasting, pre-meal, random, and bedtime); existing insulin regimen (type, dose, timing); renal function; hypoglycemia risk factors (age, BMI, total daily insulin dose, CKD, history of hypoglycemia); and nutritional status.
STEP 2 — Rule In / Rule Out
Determine if glucocorticoid dose is being changed (tapered, held, or increased) versus stable. If glucocorticoid dose is changing, proceed to adjust insulin; if dose is stable, maintain current insulin regimen and continue routine monitoring.
STEP 3 — Classify or Stratify
Stratify glucocorticoid change magnitude: low (≤25% dose change), moderate (25‑50%), or high (>50%). Also classify insulin regimen as NPH‑based or basal‑bolus (BBI) to guide adjustment magnitude.
STEP 4 — Decide
For NPH‑based regimens, adjust the total daily NPH dose by approximately 10‑20% per 25% glucocorticoid change (increase for rising GC, decrease for taper); for BBI, adjust basal and prandial components proportionally. Set monitoring frequency to POC‑BG every 4‑6 hours (or more often if hypoglycemia suspected) and reassess after each glucocorticoid dose change.
Clinical Guardrails / Mimics / Pitfalls
Avoid making insulin adjustments based on a single BG value; never use sliding‑scale insulin alone for GC‑associated hyperglycemia; do not discontinue insulin abruptly during glucocorticoid taper; safeguard against hypoglycemia by checking for risk factors and holding or reducing insulin if BG <70 mg/dL; confirm CGM trends with POC‑BG before dosing changes.
Concrete Clinical Example
A patient on prednisone 40 mg daily develops hyperglycemia (BG 180‑250 mg/dL) and is started on NPH 10 U each morning. When prednisone is tapered to 20 mg daily, the NPH dose is reduced to 8 U each morning. POC‑BG is checked q6h; if BG falls below 70 mg/dL, the NPH dose is held and reassessed.
Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, DOI: 10.1210/clinem/dgac278
